SPP1 and rheumatoid arthritis: For example, Agnihotri et al. demonstrated that anti-OPN antibodies significantly reduced cartilage erosion and inflammation in a collagen-induced arthritis model, supporting the potential of these antibodies as therapeutic tools for RA [141].